Zobrazeno 1 - 10
of 418
pro vyhledávání: '"Anthony W Kim"'
Autor:
Victoria Yin, MD, MPH, Sean C. Wightman, MD, Takashi Harano, MD, Scott M. Atay, MD, Anthony W. Kim, MD
Publikováno v:
JTCVS Open, Vol 21, Iss , Pp 349-357 (2024)
Objective: To determine factors significantly associated with alternative discharge destination (ADCD) following lobectomy, including the modified 5-item Frailty Index (mFI-5). Methods: Patients in the 2017-2020 NSQIP who underwent elective lobectomy
Externí odkaz:
https://doaj.org/article/a6427980840c4549af01c61d817426f7
Autor:
Victoria Yin, BA, Alexander T. Kim, BA, Sean C. Wightman, MD, Takashi Harano, MD, Scott M. Atay, MD, Anthony W. Kim, MD
Publikováno v:
JTCVS Open, Vol 17, Iss , Pp 322-335 (2024)
Objective: To use a nationwide database of hospitalizations to investigate underweight status as a risk factor for postesophagectomy complications. Methods: We identified all patients who underwent esophagectomy with a diagnosis of esophageal cancer
Externí odkaz:
https://doaj.org/article/c6b930a123e54068895dd8c2a04e199d
Autor:
Arman Ashrafi, BA, Li Ding, MD, MPH, Scott M. Atay, MD, Sean C. Wightman, MD, Takashi Harano, MD, Anthony W. Kim, MD
Publikováno v:
JTCVS Open, Vol 15, Iss , Pp 468-478 (2023)
Objective: To quantify the compounding effects of social determinants of health on time to surgery (T2S) and clinical outcomes. Methods: The National Cancer Database was queried for treatment-naïve patients with cT1-4N0-1M0 non–small cell lung can
Externí odkaz:
https://doaj.org/article/865336b3d01042548aac5d04c662d171
Autor:
Arman Ashrafi, BA, Jeremy Yu, MS, Alexander T. Kim, BA, Jason C. Ye, MD, Elizabeth A. David, MD, Sean C. Wightman, MD, Scott M. Atay, MD, Takashi Harano, MD, Anthony W. Kim, MD, MS
Publikováno v:
JTCVS Open, Vol 14, Iss , Pp 472-482 (2023)
Objective: The study objective was to determine differences in survival depending on adjuvant therapy type, timing, and sequence in node-negative disease with positive margins after non–small cell lung cancer resection. Methods: The National Cancer
Externí odkaz:
https://doaj.org/article/09ff31b5ea6d4dd481e5328874f2606e
Autor:
Terrance Peng, MPH, Albert J. Farias, PhD, Kimberly A. Shemanski, MD, Anthony W. Kim, MD, Sean C. Wightman, MD, Scott M. Atay, MD, Robert J. Canter, MD, MAS, Elizabeth A. David, MD, MAS
Publikováno v:
JTCVS Open, Vol 11, Iss , Pp 286-299 (2022)
Objective: This qualitative study sought to uncover factors that influence decisions to offer curative-intent surgery for patients with advanced-stage (stage IIIB/IV) non–small cell lung cancer. Methods: A trained interviewer conducted open-ended,
Externí odkaz:
https://doaj.org/article/dfba68382d3148248c2fe02479b83770
Autor:
Terrance Peng, MD, MPH, Sean C. Wightman, MD, Li Ding, MD, MPH, Dustin K. Lieu, MD, Scott M. Atay, MD, Elizabeth A. David, MD, MAS, Anthony W. Kim, MD
Publikováno v:
JTCVS Open, Vol 10, Iss , Pp 356-367 (2022)
Objective: The objective was to compare overall survival (OS) between lobectomy and segmentectomy for patients with non–small cell lung cancers (NSCLCs) > 2 but ≤4 cm. Methods: The National Cancer Database was queried to identify treatment-naïve
Externí odkaz:
https://doaj.org/article/30a5c3c8b7da4fedbe7fc4e1f0e8e5b3
Autor:
Jennifer C. Wang, BS, Li Ding, MD, MPH, Elizabeth A. David, MD, MAS, Scott M. Atay, MD, Sean C. Wightman, MD, P. Michael McFadden, MD, Takashi Harano, MD, Anthony W. Kim, MD
Publikováno v:
JTCVS Open, Vol 10, Iss , Pp 384-392 (2022)
Objectives: T3 disease comprises heterogeneous morphologic characteristics, a variation only further complicated when in the context of N2-confirmed involvement. This study aims to examine whether or not specific features of T3 N2 non–small cell lu
Externí odkaz:
https://doaj.org/article/3c84d86e40f849c8896b504f340f43ad
Autor:
Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, Ke Liu, Ying Wu, Yan Ling, Wen-Xing Qin, Miao-Miao Wang, Ling-Yan Yuan, Savio George Barreto, Anthony W. Kim, Kimberley Mak, Hao Li, Yuan-Yuan Xu, Xiao-Ming Qiu, Min Wu, Min Jin, Li-Chao Xu, Yi Zhong, Hui Yang, Xue-Qin Chen, Yu Zeng, Jun Shi, Wen-Yu Zhu, Qing-Qing Ding, Wei Jia, Su-Fen Liu, Jun-Jing Zhou, Hong Shen, Shi-Hua Yao, Zhao-Ji Guo, Ting Li, Pei-Juan Zhou, Xue-Wei Dong, Wen-Feng Lu, Robert L. Coleman, Mehmet Akce, Chérif Akladios, Francesco Puccetti, Yuan-Sheng Zang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeWe evaluated he effects of molecular guided-targeted therapy for intractable cancer. Also, the epidemiology of druggable gene alterations in Chinese population was investigated.Materials and methodsThe Long March Pathway (ClinicalTrials.gov id
Externí odkaz:
https://doaj.org/article/57373dea8a5b45d1b3cb59515c3222e3
Autor:
Jay M. Lee, MD, Anthony W. Kim, MD, Tomasz Marjanski, MD, PhD, Pierre-Emmanuel Falcoz, MD, PhD, Masahiro Tsuboi, MD, PhD, Yi-Long Wu, MD, Shawn W. Sun, PharmD, Barbara J. Gitlitz, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100221- (2021)
Neoadjuvant immunotherapy may improve outcomes in patients with resectable NSCLC and is being evaluated in phase 2 and 3 studies. Nevertheless, preoperative treatment postpones resection; the potential for increased surgical complexity and greater in
Externí odkaz:
https://doaj.org/article/fba21396acdf4e6fa8789e3a680a3b71
Autor:
Terrance Peng, MPH, Sean C. Wightman, MD, Li Ding, MD, MPH, Scott M. Atay, MD, Evan T. Alicuben, MD, Elizabeth A. David, MD, MAS, Anthony W. Kim, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100186- (2021)
Introduction: The objective of this study was to compare overall survival (OS) between patients with pT1-2N1 versus pT3N0 NSCLC and various subtypes of pT3N0 NSCLC. Methods: The National Cancer Database was queried to identify treatment-naive patient
Externí odkaz:
https://doaj.org/article/d523ee07d3de4d4c916fdbebe645196d